Community-based non-pharmacological interventions for pregnant women with gestational diabetes mellitus: a systematic review

DOI: https://doi.org/10.21203/rs.3.rs-1715121/v1

Abstract

Background

Non-pharmacological interventions are the first line of Gestational diabetes mellitus (GDM) management. Community-based interventions are cheaper, more accessible, with higher patient satisfaction.

Objectives

To systematically review community-based non-pharmacological interventions and evaluate their effectiveness for GDM.

Search Strategy

Twelve bibliographic databases and reference list of related studies from inception until January 2022.

Selection Criteria

All primary studies of community-based non-pharmacological interventions for GDM reported in English which investigated any behavioural or clinical outcome(s).

Data Collection and Analysis

Data were extracted using modified Cochrane’s data extraction template. Studies were evaluated using Cochrane Collaboration’s risk of bias tool. Narrative synthesis was used to summarise findings. This study is registered with PROSPERO (CRD42021257634).

Main Results

27 studies involving 6,242 pregnant women with GDM involved self-management programmes, medical nutrition/diet therapy, exercise/physical activity, combined diet and exercise, calcium plus vitamin D supplementation, and continuous glucose monitoring. Self-management programmes were more effective than routine care in improving self-efficacy, two-hour postprandial blood glucose, and lifestyle behaviours but were as effective as routine care in improving infant birth weight. Self-management programmes were superior to or as effective as usual care in improving fasting blood glucose, blood glucose control, glycated haemoglobin, macrosomia, and preterm delivery. Medical nutrition/diet therapy was more effective than usual care in improving postprandial blood glucose levels. Limited/conflicting evidence was found for other outcomes and interventions.  

Conclusions

Community-based non-pharmacological interventions are more effective than placebo; and are more or as effective as usual care. Self-management programmes and medical nutrition/diet therapy had the most promising GDM outcomes. 

Introduction

Gestational diabetes mellitus (GDM) is diagnosed by the detection of hyperglycaemia during pregnancy. This can convert a natural process to one fraught with increased risk for foetal and maternal mortality and morbidity, an increased need for surveillance, increased emotional distress, and reduced quality of life 1,2. Five percent of women develop type 2 diabetes within 10 years following first onset of GDM35. The prevalence of GDM is 1% – 30% globally. The burden is greatest in the Middle East and some North African countries (8.8–20.0%), followed by South- East Asia (9.6–18.3%), the Western Pacific (4.5–20.3%), South and Central America (7.1–16.6%), sub-Saharan Africa (8.5–13.1%) and North America and the Caribbean (6.5–11.9%). The lowest burden of GDM is found in Europe, and this region also has the widest variation in prevalence (1.8–31.0%)2,6.

Treatment of GDM aims to prevent foetal overgrowth and pregnancy complications and involves non-pharmacological and pharmacological modalities. Pharmacological treatments are utilized when non-pharmacological interventions do not achieve glycaemic control. Insulin therapy is the main pharmacological intervention, but it is associated with discomfort, increased cost, and risk of hypoglycaemia, requiring regular hospital visits and dose adjustments. Hence, glucose lowering oral medications such as metformin are becoming popular. Non-pharmacological interventions include mainly diet and physical activity2 and are often sufficient to achieve glycaemic control 7,8. Psychological and health education interventions may be relevant including health behaviour changes such as self-monitoring of blood glucose levels911.

Community-based treatment is associated with lower costs, higher patient satisfaction, fewer hospitalizations and emergency department visits, and lower mortality12,13. Community-based interventions are often outside large health institutions such as primary health care and general community settings, can involve non-medical personnel, have behavioural expectations and active participation, are culturally sensitive rather than routine, and are usually not intrusive14. Community-based interventions can be seen as multicomponent interventions that combine individual and environmental change strategies across multiple settings aiming to prevent diseases and to promote well-being among population groups outside of mainstream secondary and tertiary health facilities15.

There is no synthesized evidence on community-based non-pharmacological interventions for GDM. Therefore, we aimed to systematically summarise the evidence regarding community-based non-pharmacological interventions for GDM, including intervention content and effectiveness. We reported this systematic review in line with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 and the Synthesis without meta-analysis (SWiM) in systematic reviews reporting guidelines 16,17.

Methods

Eligibility criteria, information sources, selection process, data items, assessment of reporting bias and certainty assessment are detailed in Table 1.  

Table 1

 Methods for study eligibility, study selection, extracted data items, funding source, assessment of reporting bias, and certainty assessment  

Eligibility criteria

Information sources

Selection process

Data items

Assessment of reporting bias

Certainty assessment

We included all primary studies RCTs, non-RCTs, pre-test/post-test studies, observational studies, and qualitative studies) published in English, that investigated all types of community-based non-pharmacological interventions for pregnant women with GDM. We defined ‘community’ as settings outside of tertiary and secondary health facilities including primary health care centers, outreach centers, schools, churches, small community clinics within rural or urban areas. We defined non-pharmacological interventions as that do not involve the use of medications and surgery as treatment. We included interventions administered by anyone (including health professionals, alternative practitioners, or peers). All intervention delivery modes (face-to-face, telephone-based, web-based, etc.) were eligible for inclusion. There was no restriction of studies in relation to control groups and timing of assessment or intervention delivery. The primary outcome of this review is change in any health behaviour. The secondary outcomes include all clinical outcomes such as blood glucose levels, insulin sensitivity, gestational hypertension, preeclampsia, etc. We excluded publications without primary data or duplicate publications. 

 

The Health Inter-Network Access to Research Initiative (HINARI) platform was used to search PubMed, CINAHL, CENTRAL, Global Index Medicus, African Index Medicus, African Journal Online, WPRIM (Western Pacific Region Index Medicus), LILACS (Latin American and Caribean Centre on Health Science Information), IMSEAR (Index Medicus for South-East Asia Region), IRIS (WHO digital publications), BLDS (British Library for Development Studies) from inception until August 2020.  Additional studies were located from Google scholar and the reference list of relevant studies and systematic reviews. An update to all searches was done covering the period from September 2020 to January 2022.

Literature search results were imported into Mendeley and deduplicated before exportation into Microsoft Excel 2007 to facilitate the management of articles and selection of studies for inclusion into the review based on the eligibility criteria.

Screening was done in two stages. Firstly, two trained reviewers (PCO, GNE) independently screened the title and abstracts of the retrieved studies and identified studies that apparently met the eligibility criteria. Disagreements at this stage were resolved by discussion between the two reviewers and forwarding the full texts of such studies to the second stage of screening. Secondly, PCO and GNE independently read through the full texts of selected studies and identified those that were eligible for the review.  Disputes at this stage was resolved by the third reviewer (CNI-C). Details of study selection are presented in a flow chart (Figure 1). 

 

Study citation (authors’ names and year), the country where the study was conducted, participants’ characteristics (age, occupation and education), sample size, study design, intervention description, who delivered the intervention, intervention duration, intervention follow-up, attrition, results of outcome(s) assessed, and the risk of bias in each study were collected from included studies. 

 

We checked if the rating of bias, study design and the size of study influenced consistent and inconsistent outcomes reported by more than one study.

We used the principles of Grading of Recommendation, Assessment, Development and Evaluations (GRADE) to assess the overall strength of evidence for each outcome based on inconsistency, imprecision, indirectness, and publication bias. Overall strength of evidence was rated as very low (very uncertain effect estimates), low (effect estimates will very likely change with further research), moderate (effect estimates will likely be affected by further research), and high (effect estimates unlikely to change with further research). 

 

 

Search strategy 

Search strategies for the twelve databases were informed by the Cochrane handbook for systematic reviews of interventions 18. In line with the PRISMA 2020 guidelines 16,19, searches involved several combinations of MeSH and free text terms and word variants for pregnant, gestational diabetes, community-based and non-pharmacological interventions. Search strategies were developed for the different databases and was piloted to establish sensitivity prior to searching (appendix 1). 

Data collection process

Data were collected using a data extraction form that was adapted from the Cochrane Group’s Data Extraction Template 20. Three reviewers (CNI-C, PCO, GNE) independently piloted the form on a random sample of 5 articles. Final amendments were made to the form prior to data extraction. PCO and GNE independently extracted data from studies. Inconsistencies in extracted data were resolved by discussion with CNI-C. A maximum of three email requests were made to corresponding authors of studies with missing or unclear information. 

Study risk of bias assessment

Two reviewers (CNI-C, PCO) independently assessed the risk of bias in all RCTs. Other study designs were regarded as high risk of bias. The risk of bias in RCTs were assessed using the Cochrane’s risk of bias tool including selection bias, performance bias, detection bias, attrition bias, reporting bias and other potential threats to validity 21. For each RCT, low risk of bias in all domains was classified as low risk of bias overall. High risk of bias or unclear risk of bias in only one item was classified as minimal risk of bias overall. High risk of bias or unclear risk of bias in two to three items was classified as moderate risk of bias overall. High risk of bias or unclear risk of bias in four items and above was classified as high risk of bias overall.

Synthesis methods

Narrative synthesis was used due to clinical, methodological, and statistical heterogeneity arising from diverse interventions, study designs, methods, and outcomes, respectively. 

This systematic review is registered with PROSPERO (CRD42021257634) and the protocol is available online.

Results

Study selection

1 816 duplicates were removed from the initial search yield of 9 162. 7 346 titles and abstracts were screened, and 109 full text articles were screened. 25 articles were eligible. Two RCTs were included from the update search. A total of 27 articles were included in this review: 16 RCTs and 11 quasi-experimental studies (Figure 1). 

Study Characteristics

Included study characteristics are illustrated in Table 2. Identified studies were published between 2004 and 2021; and involved 6,242 pregnant women with gestational diabetes mellitus in China (6), Iran (5), United State of America (3), Canada (2), Australia (1), Brazil (1), Croatia (1), Egypt (1), Ireland (1), Japan (1), Mexico (1), Nigeria (1), Oman (1), Thailand (1), and Turkey (1). The community-based non-pharmacological interventions were delivered in primary health care centres (antenatal/maternal clinics) (8), private community clinics (5), obstetric community clinics (3), gestational diabetes mellitus community clinics (3), perinatology community clinics (2), outpatient community clinics (2), medical centre (1), and urban community clinic (1) by researchers (9), dieticians/nutritionists (4), physicians and researchers (2), physicians (2), nurses (2), physiotherapists (1), educators (1), physician and nurses (1), educator and physicians (1), exercise physiologist and nurse (1), midwives and nurses (1), dietician and nurse (1), not specified (1). The control interventions were delivered in the same facilities.  

Table 2

 Characteristics of studies of pregnant women with gestational diabetes 

Author (year)

Country

Participant characteristics

Study sample size

Study design

Who delivered the intervention

Intervention duration and follow-up periods

Attrition rate

 

 

Age (range or average in years)

Occupation

Education

 

 

 

 

 

Daniel et al., 2014

Nigeria

I=32 C=32·9

NS

NS

 

34; I=17 C=17

RCT

Physiotherapists

8 weeks

4 (I=2; C=2)

de Barros et al., 2010

Brazil

18-45

NS

NS

64; I=32 C=32

RCT

Researcher

Recruitment (gestational age ranging from 24 to 34 weeks) to end of gestation

0

Sklempe Kokic et al., 2017

Croatia

20-40

NS

Secondary: 

(I=7, C=7); 

Tertiary: 

(I=11, C=13)

42; I=20, C=22

RCT

Physicians

6 weeks (Minimum)

4

Mohebbi et al., 2019

Iran

17-41

NS

I: (illiterate =5, High school=21, diploma=20, university=9); C:(illiterate=9, 

High school=21, diploma=12, university=13)

110: I=55 C=55

RCT

Educator

6 months 

0

Yang et al., 2018

China 

18-45

NS

NS

157: I=(A=57; B=50) C=50

Non-randomized controlled design

Obstetrician, Researchers

NS

0

Ibrahim & Saber, 2019

Egypt

≥ 18 - ≤ 40

I: (not working=24, working=16); C: (not working=32, working=8)

I: (not educated =2, intermediate education=20, university / academic=18); 

C: (not educated=14, intermediate education=18, university/ academic=8)

80; I=40, C=40

Non-randomized controlled design

Researcher

NS

0

Bartholomew et al., 2015

USA

≥18

NS

51·4% College Graduates; 24·3% completed some college; 20·3% completed 12th grade, graduated high school, or earned a general education diploma; and 4·1% had < a 12th-grade education.

100; I=50, C=50 

RCT 

Maternal Foetal Medicine Physician and Nurses

6 weeks

26

Yu et al., 2014

China 

28-36

NS

NS

340; I=150, C=190

Prospective Cohort Study

Research Nurses

5 weeks

3

Sunsaneevithayakul et al., 2004

Thailand 

Over 30

NS

NS

54

Case series

Diabetes nurse educator and physicians

3 days

0

Hu et al., 2014

China 

I:30·3 ± 4·9; C:29·7 ±3·7

NS

NS

140; I=66 C=74

RCT

Dietitians 

5 days

0

Louie et al., 2011

Australia

26-42

NS

NS

99: LGI=50; HF=49

RCT

Endocrinologist

NS

7

Asemi et al., 2014

Iran

18-40

NS

NS

58; I=29, C=29

RCT

NS

4 weeks; Follow-up: once a week

6; I=3, C=3

Grant et al., 2010

Canada

18-45

NS

NS

47; I=24, C=23

RCT

Dietitian

8 weeks

4

Artal et al., 2007

USA

Over 18

NS

NS

96; ED=39, D=57

Non-randomised controlled trial

Exercise physiologist, Diabetes nurse Dietitian

NS

8; ED=2, D=6

Kgosidialwa, et al., 2015

Ireland 

I= 33·4±4·9 C=31·5±5·2

NS

NS

3066; 

I=567, C=2499

Retrospective Cohort

Midwife and diabetes nurse 

NS

0

Wang et al., 2015

China 

22-35

NS

High school education (81·7 %)

14168; GDM-E=2061; GDM-nE=689; non-GDM =11418

Retrospective cohort 

Researchers

6 months

0

Mendelson et al., 2008

USA

18-40

NS

NS

100; I=49, C=51

RCT

Nurses

NS

0

Ural & Beji, 2021

Turkey

18 or older

I= (Housewife=30, 65·2%; Civil servant, worker =16, 34·8%; Employed = 7, 15·2%; Unemployed = 39, 84·8%); C= (Housewife = 34, 81%; Civil servant, worker = 8, 19%; Employed = 6, 14·3%; Unemployed = 36, 85·7%)

I= (Primary= 20, 43·5%; Secondary = 19, 41·3%; Higher education=7, 15·2%); C= (Primary school=28, 66·7%; Secondary school=9, 21·4%; Higher education=5, 11·9%)

100; I=50, C=50

RCT

Researchers 

Intervention duration: 3 days. Follow-up: 2 weeks after the education program and 2nd week of the postpartum.

12; I=4, C=8

Kolivand et al., 2019

Iran

I=32·4 ± 5·6

C= 30·2 ± 4·5

I= (Housewife = 57, 76%; Employed = 18, 24%; C= (Housewife = 65, 85·5%; Employed = 11, 14·5%)

I= (Elementary =1, 1·3%; Secondary=24, 32·0%; Diploma=26, 34·7%; University= 24, 32·0%); C= (Elementary =20, 26·3%; Secondary=11, 14·5%; Diploma=32, 42·1%; University= 13, 17·1%)

152; I=76, C=76

RCT

Researcher

Intervention duration: 7 weeks, Follow-up: 1 month

1

Al Hashmi, 2018

Oman 

19-43

Medical Professional = 16, 32·6%; Teaching Professional = 11, 22·4%; Administrative Professional = 17, 34·7%; Business / Engineering / IT Professional = 9, 15·3%. (Working: 49, 54·4%; Not working: 41, 45·6%)

Less than high school=13, 14·4%; High school graduate=30, 33·3%; Some college/College graduate=35, 44·4%; Graduate degree=7, 7·8%

90; I=45, C=45

RCT

Researcher

4 weeks

0

Shi et al., 2016

China

21-44

I: (Mental = 169, 55·05%; Manual = 53, 17·26%; Home = 85, 27·69): C:     (Mental = 103, 56·91%; Manual =29, 16·02%; Home = 49, 27·07%)

I: (High=233, 75·90%; Middle=45, 14·66%; Low=29, 9·45%); C: (High=149, 82·32%; Middle=18, 9·94%; Low=14, 7·73%)

488; I=307, C=181

Retrospective Cohort

Nutritionists

First follow-up: within 2 weeks since the initial diagnosis of GDM and the start of MNT. Further follow-up visits every 2-4 weeks

0

Perichart-Pereraet al., 2009

Mexico 

19-43

NS

NS

78; I=39, C=39

Non-randomised controlled trial

Dietitian

Follow up: with every 2 weeks until delivery

0

Murphy et al., 2004

Canada

NS

NS

Individual method: Elementary = 0, High school = 9 (26%), Post-secondary = 26 (74%); Small group method:  Elementary school = 0, High school = 6 (15%), Post-secondary = 33 (85%)

76: Individually= 35, Small groups= 41

Non-randomised controlled trial

Dietitian and Nurse

Intervention duration: 1 hour, follow-up: 1 week 

0

Hayashi et al., 2018

Japan 

29-42

NS

NS

73

Longitudinal

Researchers

7-12 weeks

49

Karamali et al., 2015

Iran

18-40

NS

NS

60; I=30, C=30

RCT

Researchers

6 weeks

0

Tian et al., 2021

China

18-45

NS

NS

309;

I= 147

C= 162

RCT

Physicians and Researchers

Every 2 weeks until delivery

23

Barati et al., 2021

Iran

18-35

Employed (88·7%)

Housewife (11·3%)

University (37·7%)

Diploma (34·0%)

No diploma (28·3%)

112;

I= 56

C= 56

RCT

Researcher

4 weeks

7

NS: Not specified; I: Intervention group; C: Control group; USA: United States of America; RCT: Randomized Controlled Trial; HBM: Health Belief Model; SMBG: Self-monitoring of Blood Glucose; LGI: Low Glycemic Index; HF: High Fibre; ED: Exercise & Diet; D: Diet; GWG: Gestational Weight Gain; DSCA: Diabetes Self-Care Activities Measure; DMSES: Diabetes Management Self-Efficacy Scales; HPLP II: Health-Promoting Lifestyle Profile II; SF-36: Short Form 36 Health Survey: CES-D: Center for Epidemiologic Studies Depression Scale; BMI: Body mass index; FBG: Fasting blood glucose; CGMS: Continuous glucose monitoring system; I = intervention; C= control; GDM-E: Gestational Diabetes Mellitus-Exercise; GDM-nE: Gestational Diabetes Mellitus-non Exercise; non-GDM: non-Gestational Diabetes Mellitus; HbA1c: glycated haemoglobin.

Risk of bias in studies

Table 3 highlights the risk of bias in individual RCTs. Overall, two RCTs were low risk of bias, two RCTs were minimal risk of bias, eight RCTs were moderate risk of bias, and three RCTs were high risk of bias. All eleven quasi-experimental studies were regarded as high risk of bias.   

Table 3

 Risk of bias table for the randomised controlled trials (RCTs)

Author’s name and year

Random sequence generation (selection bias)

Allocation concealment (selection bias)

Blinding of participants and personnel (performance bias)

Blinding of outcome assessment (detection bias)

Incomplete outcome data (attrition bias)

Selective reporting (reporting bias)

Other biases

Overall grading of bias

Karamali et al. 2015

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Louie et al., 2011

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

de Barros et al., 2010

Low risk

Low risk

Low risk

Low risk

Low risk 

Low risk

Low risk

Low risk

Kolivand et al., 2019

Low risk

Low risk

Low risk

Unclear 

Low risk

Low risk

Low risk

Minimal risk 

Sklempe Kokic et al., 2017

Low risk

Low risk

High risk 

Low risk

Low risk

Low risk

Low risk 

Minimal risk

Tian et al., 2021

Low risk

Unclear 

Low risk 

Unclear 

Low risk

Low risk

Low risk

Moderate risk

Barati et al., 2021

Low risk

Low risk

High risk

Unclear

Low risk

Low risk

Low risk

Moderate risk

Mohebbi et al., 2019

High risk

Low risk

Unclear 

Low risk

Low risk

Low risk

Low risk

Moderate risk

Al Hashmi, 2018

Low risk

Unclear

High risk 

Low risk

Low risk

Low risk

Low risk

Moderate risk

Bartholomew et al., 2015

Low risk

Low risk

High risk

Low risk

High risk

Low risk

Low risk

Moderate risk

Asemi et al., 2014

Low risk

Unclear

Unclear

Unclear

Low risk

Low risk

Low risk

Moderate risk

Grant et al., 2010

Low risk

Low risk

Unclear

Unclear

Low risk

Low risk

High risk

Moderate risk

Mendelson et al., 2008

Low risk

High risk

High risk

High risk

Low risk

Low risk

Low risk

Moderate risk

Daniel et al., 2014

Unclear 

Unclear 

Unclear

Unclear

Low risk

Low risk

Low risk

High risk

Hu et al., 2014

Unclear

Unclear

Unclear

Unclear

Low risk

Low risk

Low risk 

High risk

Ural & Beji, 2021

High risk

High risk

High risk

High risk

Low risk

Low risk

Low risk

High risk

  

Results of individual studies 

Table 4 presents the description of the community-based non-pharmacological interventions and the control group interventions as well as the results of each study.

Table 4

Results of each individual study included 

S/N

Author’s name and year

Overall risk of bias

Community-based non-pharmacological interventions and duration 

Control group interventions and duration

Results in favour of experimental (community-based non-pharmacological) interventions

Results in favour of control group interventions

No difference in the outcomes of both groups – 

1

Karamali et al. 201548

Low risk

Calcium and vitamin D supplements.  

1000 mg Ca/d and two pearls containing 1250 μg (50 000 IU)

of cholecalciferol (vitamin D3) during the intervention (one at study baseline and

another at day 21 of the intervention) 

Two placebos of vitamin D at the mentioned times and placebos of Ca every day

for 6 weeks.

Significant decrease in

caesarean section rate (23·3% vs 63·3%, P = 0·002) and maternal hospitalization

(0 vs 13·3%, P = 0·03) compared with those receiving placebo

 

Newborns of GDM women randomized to Ca + vitamin D had no case of

macrosomia, while the prevalence of macrosomia among those randomized to

placebo was 13·3% (P = 0·03).

Lower rates of hyperbilirubinaemia (20·0% v.

56·7%, P = 0·03) and hospitalization (20·0% vs 56·7%, P= 0·03) were also seen in the supplemented group of newborns than in the placebo group.

                – 

                –

2

Louie et al., 201133

Low risk

Low–glycaemic index (LGI) diet: low GI (target GI ≤ 50)

 

healthy diets of similar protein (15–25%), fat (25–30%), and carbohydrate (40–45%)

content

Conventional high-fibre diet: moderate GI (target GI ≈ 60)

 

healthy diets of similar protein (15–25%), fat (25–30%), and carbohydrate (40–45%)

content

                –

                –

LGI diet and a conventional

HF diet produced similar pregnancy outcomes. Average infant birth weight, birth weight centile, and ponderal index were within healthy norms in both groups.

 

Fewer women in the LGI group gained an excessive amount of

weight but this was not statistically significant (LGI 25% vs.

HF 42%; P = 0·095).

 

Compliers in the LGI

group appeared to gain less weight than

those in the HF group although this was not statistically significant (LGI 11·2±0·9 kg vs HF 13·7±1·0 kg; P = 0·073).

 

No significant difference in foetal abdominal circumference at 36-37 weeks’ gestation (mean ± SEM LGI 327·6 ± 19·2

mm vs HF 322·6 ± 14·6 mm; P = 0·186).

3

de Barros et al., 201042

Moderate risk

Exercise group 

underwent a resistance exercise programme until

the end of gestation PLUS routine prenatal care PLUS systematic evaluation and diabetic dietary instructions from a nutritionist. Resistance exercise was performed with an elastic band. The patients were advised to start the program about 90 minutes after consuming a meal of their preference

(breakfast, lunch, or dinner) and after the measurement of capillary glycemia with an Accu-Chek Advantage glucose meter (Roche Diagnostics, Indianapolis,

IN). If capillary glucose levels were between 100 and 250 mg/dL, exercise group patients

started the program with a stretching sequence.

If capillary glycemia was below this range, the patients were instructed to do the resistance exercise program on the next day to prevent hypoglycemia. If the values were above this range, the patients were instructed

not to undergo resistance exercise to prevent the occurrence of ketoacidosis and to contact the responsible obstetrician. 

 

The resistance exercise program consisted of a circuit type resistance training, elaborated in such a way that the main muscle groups of the patients would be exercised (chest, back, biceps, triceps, deltoid, quadriceps, thigh, and calf muscles). 

 

A circuit series was defined as a sequence of these eight exercises (stations). The women performed 15 repetitions of each exercise

(station), with a minimum resting period of 30 seconds and a maximum of 1 minute between each one. In the first and second week of follow-up, the women underwent 2 circuit series, followed by 3 circuit series from the third week of inclusion in the study to the end of gestation.

 

Exercise intensity was controlled by the women themselves using a perceived exertion scale for resistance exercise provided to them.

The women were advised to maintain an exercise intensity close to 5 or 6, which corresponds to a “somewhat heavy” exercise perception. 

 

The patients received written guidelines of how to perform each exercise and were instructed to undergo the program on 3 non-consecutive days a week (twice a week at home). 

 

The participants were contacted by telephone at least once a week to verify adherence to the program.

 

The other session was 

performed during the weekly return visit, always under the supervision of the lead researcher. On that occasion, the patients were asked whether they had performed any type of physical activity

other than resistance exercise. In addition, the adequate

execution of resistance exercise at the correct intensity was verified.

Routine prenatal care PLUS systematic evaluation and diabetic dietary instructions from a nutritionist. 

A significant decrease in the number of patients who required insulin was observed in exercise group compared with control group.

 

Glycemic control was significantly better in exercise group compared with control group. In exercise group, the percentage of weeks spent within the target glucose range (80% of weekly capillary glucose measurements within preestablished guideline values) was significantly higher when compared with control group.

 

Newborn birthweight greater than 4000 g was observed in 1 EG case and 3 CG cases.

 

                –

No significant difference in mean (SD) glucose levels was observed between exercise and control groups.

 

Mean glucose levels measured by the patients at different times of the day throughout the follow-up period were lower in exercise group compared with control group, but the difference was not significant.

 

The 2 groups did not differ significantly in terms of the amount of insulin (international units per kilogram) required by the patients or in the time interval (weeks) between inclusion in the study and insulin use.

 

Exercise group patients who used insulin continued to present adequate glycemic control according to the target established for a longer percent period of weeks than control patients who used insulin (EG: 0·40 (0·24) vs CG: 0·25 (0·23), but the difference was not significant (P=0·173). 

 

No significant difference in mean glucose levels was observed between patients of the 2 groups who used insulin (CG: 106·83 (7·45) vs EG: 109·83 (9·04) mg/dL; P=0·342). 

 

No difference

in the frequency of cesarean section was

observed between groups (n: 21 of 32 in EG vs n 24 of 32 in CG; P=0·412).

 

3 cases of preterm

delivery in each group (gestational age at

birth ranging from 35 to 36 weeks).

4

Kolivand et al., 201924

 

Minimal risk 

New self-care guide package plus three face-to-face educational sessions

Routine clinical services: physician visits and short training regarding nutrition, blood glucose control, and insulin injections

 

Superior effects on maternal self-efficacy and 2-h postprandial plasma glucose, Apgar scores, and neonatal hospitalization.

 

 

The mean (±SD) self-efficacy score was higher in the intervention than control group (74·4 ± 7·0 vs 36·4 ± 5·2, respectively; P < 0·001).

 

Mean 2-h postprandial plasma glucose was lower in the intervention than control group (105·1 ± 17·6 vs 127·2 ± 20·4 mg/dL, respectively; P < 0·001).

 

Newborn hospitalization rate was higher in the control group (P < 0·001).

 

 

                –

No significant difference in mean fasting plasma glucose between the two groups (P = 0·163)

 

 

 

No significant differences in the weight and age of the neonate at delivery or in the type of delivery between the two groups.

 

 

5

Kokic et al., 201743

Minimal risk

Experimental group was treated with standard antenatal care for gestational diabetes mellitus, and regular supervised exercise programme plus daily brisk walks of at least 30 minutes. The exercise programme was started from the time of diagnosis of diabetes until birth. It was performed two times per week and sessions lasted 50–55 min.

Control group received only standard antenatal care for gestational diabetes mellitus.

The experimental group had lower postprandial glucose levels at the end of pregnancy (P < 0·001).

Neonatal body mass index was higher in the experimental group (P = 0·035).

No significant difference between groups in the level of fasting glucose at the end of pregnancy.

 

No significant differences in the rate of complications during pregnancy and birth, need for pharmacological therapy, maternal body mass and body fat percentage gains during pregnancy, and neonatal Apgar scores, body mass and ponderal index.

6

Tian et al., 202125

Moderate risk

Health education and lifestyle management delivered through a WeChat group chat

Participants received WeChat group management in addition to standard clinical prenatal care. Participants received management on a weekly basis. In particular, every

Monday, researchers would issue a briefing to encourage patients to take an active part in the control of their GDM and a task card to pinpoint the basic requirements, including diet advice, examples of meals from other group members, and exercise rules. Patients performed self-management according to the basic criteria provided for their actual situation and shared

photos of their meals and snacks, daily exercise, and experience regarding BG control. Researchers would give individualized

guidance for self-management or use a group member’s situation as an example for others. On weekends, the researchers prepared lessons and articles for group members to

learn different aspects of pregnancy and GDM, including rudimentary knowledge, disease management, psychology, and past cases. We encouraged the sharing of learning experiences

and notes in the form of peer interactions and support groups. If there were any questions regarding the project, pregnancy, or GDM, patients could seek answers from the group chat. This weekly management continued until delivery.

Standard clinical prenatal care

Participants were taught basic information about GDM and how

to do self-management, including how to conduct blood glucose monitoring, what the target BG values are, and how to keep a lifestyle diary.

Additional instant messaging platforms, such as WeChat, used for health education and lifestyle intervention in China tend to be more effective for blood glucose control than standard clinical prenatal care alone.

 

The glycemic qualification rate of the intervention group was higher than that of the control group at nearly all time points in Groups 1 to 3, among which 3 time points reached statistical significance: Group 1 at T3 (54·8% vs 83·3%) and Group 2 at T3 (62·5% vs 80·0%) and T7 (75·0% vs 100%).

                –

None of the pregnancy outcomes measured, including delivery mode, premature rupture of the membranes, preterm birth, infant's birth weight, and postpartum hemorrhage, were significantly different between the control and intervention groups.

7

Barati et al., 202136

Moderate risk

30 grams of oat bran daily for 4 weeks at lunch and dinner PLUS diet for gestational diabetes.

 

Routine diet for gestational diabetes.

The addition of oat bran to the standard diet for pregnant women with gestational diabetes reduced fasting blood glucose and two-hour postprandial glucose.

 

Mean fasting blood glucose and two-hour

postprandial glucose decreased significantly in the intervention group compared with the control group

(P < 0·001).

 

Two weeks after the start of oat bran consumption, the mean two-hour postprandial glucose was 122·17 (3·91) in the control group and 115·37 (3·14) in the oat bran group, which was significantly different (p < 0·001).

 

Four weeks after start of the consumption of oat bran, the mean two-hour postprandial glucose was 117·49 (11·34) in the control group and 104·04 (5·48) in the oat bran group, which was significantly different (P < 0·001).

                –

The two groups were not significantly different in terms of average fat intake (p = 0·67), average carbohydrate intake (p = 0·28), protein intake (p = 0·23) and fibre intake (p = 0·46).

8

Mohebbi et al., 201926

Moderate risk

Self-management education programme was presented in four sessions lasting 35-40 minutes for each during a month. 

 

Phone calls as small booster were conducted which served as a quick reference to education and reminder to study participants. 

 

Content of educational programs included basic information regarding GDM facts, figures and self-management based on HBM constructs like perceived susceptibility and severity of gestational diabetes, barriers and benefits of self-management and perceived self-efficacy and self-management incorporating cues to actions. 

 

Strategies such as setting achievable goals and use of motivational interviewing to increase self-efficacy were also used in educational sessions. 

 

Ways of social support from family were considered offering empathy, concern, encouragement, or caring to the women. 

 

Moreover, self- monitoring of blood glucose was used as a way to teach participants about their disease using pictures and simple instructions. 

 

At the end of each session, the educator reviewed the important topics of the session and women were encouraged to ask their questions which were answered accordingly.

Routine clinic-based education.

There were significant (P<0·001) improvements in the self-management education programme group compared to the control group at 3 and 6 months after the intervention in all outcomes including HbA1c, self-management, self-efficacy, cues to action, perceived benefits, perceived barriers, perceived severity, perceived susceptibility

                –

                –

9

Al Hashmi, 201827

 

Moderate risk

Self-efficacy-enhancing intervention (SEEI) PLUS standard antenatal care. The SEEI group received an additional individualised health education intervention utilising different self-efficacy-enhancing strategies (i.e. motivational messages, role modelling, goal-setting and mastery experience) designed to encourage women to maintain recommended healthy behaviours. First,

the participants watched an educational video designed solely for the purposes of the study. The video focused on general information about GDM and GDM-related maternal and neonatal complications, as well as information about the importance of healthy lifestyle behaviours— such as a healthy diet, exercise and maintaining self-monitored BG levels to prevent GDM complications— and measures to prevent post-partum T2DM. The physical activities recommended in the video conformed with standard cultural beliefs and religious practices in Oman by focusing on safe exercises which could be conducted indoors and in private (i.e. walking, swimming and dancing). After watching the video, participants in the SEEI group were encouraged to practice the recommended

activities during the session. The participants were provided with a BG metre and were trained to check and record their BG levels; they were requested to do this four times per day during the study period. In order to enhance adherence to the recommended healthy behaviours, the participants were encouraged to write down specific and measurable goals. A pamphlet summarising the content of the educational session was distributed to all participants before the end of the session. In addition, they received short biweekly motivational text messages for four weeks to reinforce the information given during the educational session. Finally, a refresher session was given at 32–35 gestational weeks via telephone.

Standard antenatal care, including routine antenatal visits, monthly blood sugar profiles, fasting blood sugar testing at every visit, glucose monitoring at home and individualised

educational sessions with a diabetes dietician.

The SEEI was found to significantly improve perceived self-efficacy and actual adherence to healthy behaviours among a group of Omani women with GDM. 

 

There was a significant positive difference between the SEEI and control groups in terms of pre-post change in scores for both perceived self-efficacy: 9·9  (19·6) versus −1·8 (17·6); P <0·05 and actual adherence to healthy behaviours – diet, exercise, BG monitoring: 1·5 (1·1) versus 0·4 (0·8); P <0·01.

                    –

                  –

10

Bartholomew et al., 201528

Moderate risk

The use of cell phone–Internet technology (CIT) for self-management (monitoring) of hyperglycemia during pregnancy 

 

 

3-hour diabetes educa­tion class taught by certified diabetes educators.

Women who required med­ication (insulin or glyburide) were provided personalized instruction regarding correct usage. All women received equivalent education, train­ing, and consultation regarding a carbohydrate-controlled diet, exer­cise, SMBG, and reporting SMBG results.

 

All women received the same glu­cose meters (OneTouch; LifeScan, Inc., Milpitas, Calif.) and testing supplies. They were instructed to perform SMBG four times per day (fasting and 2 hours postprandially) and record values using the reporting method to which they were assigned.

 

PLUS

Women using the CIT method were advised to upload their blood glucose results at least weekly, although they could upload at every test, every day, or at their conve­nience within that timeframe. The system uploaded every value in the meter each time an upload occurred. Uploading began by turning on the cell phone and glucose meter. The wireless device was plugged in to the glucose meter and turned on. The phone was placed within 3 feet of the wireless device. Participants pressed a menu button and then selected the “collect” option on the phone menu to start the application. A confirma­tion of data receipt was displayed on the phone. Supplementary Figure 1 shows the components of the CIT glucose meter system. Each week, MFM physicians reviewed the blood glucose values on the Web site. The nurses communicated the recommen­dations to patients by telephone.

 

Those using the CIT method could review their progress on the Web site or in graphs created on the phone.

 

They also received automatic encouraging text

messages. Sample text messages were:

• “You didn’t submit readings for

the second week in a row. Try to

submit your readings every week.”

• “Did you notice your overall glucose

average rose over the past

week?”

• “Thanks for submitting your readings.

Keep up the good work!”

 

CIT technical support was avail­able by telephone 12 hours/day. 

All women received equivalent education, train­ing, and consultation regarding a carbohydrate-controlled diet, exer­cise, SMBG, and reporting SMBG results.

 

3-hour diabetes educa­tion class taught by certified diabetes educators. Women who required med­ication (insulin or glyburide) were provided personalized instruction regarding correct usage.

 

All women received the same glu­cose meters (OneTouch; LifeScan, Inc., Milpitas, Calif.) and testing supplies. They were instructed to perform SMBG four times per day (fasting and 2 hours postprandially) and record values using the reporting method to which they were assigned.

PLUS

Women using the control method were advised to record blood glu­cose values in a log book and report their handwritten glucose results to the program nurse each week by dictating the values on the voice­mail system. Nurses listened to the voicemail messages and recorded the values on paper. MFM physicians reviewed the paper records weekly to make recommendations. Nurses then communicated the recommendations to the women by telephone.

Compliance with SMBG report­ing was higher during use of the CIT method for total, fasting, and 2-hour postprandial glucose values.

 

The mean 2-hour postprandial SMBG value was 108·3 mg/dL when the CIT method was used first and 112·7 mg/dL when the control method was used first (= 0·023).

 

The mean fasting blood glucose value was 89·5 mg/dL when CIT was used first and 92·5 mg/dL when voicemail was used first (= 0·049).

 

With regard to the secondary outcome of satisfaction, 68·9% of women preferred (“liked best”) the CIT method compared to 24·3% who said they preferred (“liked best”) the voicemail method (<0·001);

 

More than half (59·5%) of the women found the automatic text messages to be “always helpful,” whereas 24·3% found them “often helpful,” 10·8% found them “rarely helpful,” and 5·4% found them “never helpful.”

 

 

                     –

                     –

11

Asemi et al., 201437

Moderate risk

Dietary Approaches to Stop Hypertension (DASH) eating plan.

 

The DASH diet was rich in fruits, vegetables, whole grains, and low-fat dairy products, and contained lower amounts of saturated fats, cholesterol, and refined grains with a total of 2400mg/day sodium.

The control diet was designed to contain 45–55% carbohydrates, 15–20% protein and 25–30% total fat.

Consumption of DASH diet for 4 weeks among pregnant women with GDM resulted in improved

pregnancy outcomes.

 

46·2% of women in the DASH diet needed to have a caesarean section, this percentage for the control group was

80·8% (P= 0·01).

 

The percentage of those who needed to commence insulin therapy after intervention was also significantly different between the two groups (23% for DASH vs 73% for control group, P<0·0001).

 

Consumption of the DASH diet led to a significant reduction in the birth of macrosomic infants compared with the control diet (3·8 vs 38·5%, P=0·002).

 

Infants born to mothers on the DASH diet had significantly lower weight (3222·7 vs 3818·8 g, P<0·0001), head circumference (34·2 vs 35·1 cm, P= 0·01) and ponderal index (2·50 vs 2·87 kg/m3, P<0·0001) compared with those born to mothers on the control diet.

                  –

No significant difference in mean gestational age was found when comparing the DASH and control diets.

 

Prevalence of polyhydramnios was not significantly different between the two groups.

 

No significant difference in mean length and Apgar score of the newborns when comparing the DASH and control diets.

12

Grant et al., 201034

Moderate risk

Low-glycaemic-index (LGI) diet

 

Routine diabetic diet

More postprandial glucose values were within target on low-GI (58·4% of n=1891) than control (48·7% of n=1834; p<0·001).

                     –

Glycaemic control improved on both diets.

13

Mendelson et al., 200829

Moderate risk

Supplementary 1-hour education session for diabetes education PLUS usual obstetric care reinforcement by a Parish Nurse.  

Usual obstetric care

Significantly improved Health Promoting Lifestyle Profile II scores (self-reported health promoting behaviors) in the Parish Nurse Intervention Program group post-intervention compared with usual obstetric group.

                  –

No significant differences between groups regarding glycemic control, macrosomia, or days of maternal or neonatal hospitalization were found.

14

Daniel et al., 201444

High risk

8 weeks aerobic dance exercise consisting of three exercise sessions per week, 40 minutes per session for the first 4 weeks and 60 minutes per session for the last 4 weeks.

Routine care and activities of daily living

Significant improvement in the fasting blood sugar (p= 0·001) of the exercise group.

                     –

                     –

15

Hu et al., 201435

High risk

Low glycaemic index diet

 

 

Routine diabetic control diet

A low-GI staple diet significantly reduces postprandial glucose levels

 

Glucose levels were significantly reduced in the low-GI staple diet group (all P < 0·01) and the control group (all P < 0·008).

 

Postintervention glucose values after breakfast, lunch, and dinner were significantly reduced in the treatment group compared with those in the control group (all P < 0·05). 

 

The percentage changes from baseline of all glucose values were significantly greater in the treatment group than in the control group (all P < 0·05).

                  –

                  –

16

Ural & Beji, 202130

High risk

Health-Promoting Lifestyle Education Programme and usual care

Usual care

 

Improvement in the healthy lifestyle behaviours and quality of life in the intervention group.

 

The rates of macrosomia were low for the neonates in the intervention group.

                     –

                     –

17

Yang et al., 201831

High risk

WeChat platform-based using both a smartphone-based telemedicine system and articles providing continuous health education PLUS routine outpatient treatment and health education guidance

 

Routine outpatient treatment and health education guidance

 

Fasting blood glucose (FBG) and 2-h postprandial blood glucose (PBG) were significantly lower and premature delivery was significantly less likely in intervention group than in control group (all P < 0·05). 

 

Pregnancy-induced hypertension had a higher incidence in control group (P <0·05)

Compared with control group, caesarean section was more likely in intervention group (P < 0·05).

                  –

18

Ibrahim & Saber, 201932

High risk

4 educational sessions each one lasted for 30 minutes included lectures, PowerPoint, and group discussion. The educational programme involved notes on the general knowledge of gestational diabetes including definition, aetiology, high-risk groups, clinical manifestation, maternal and foetal complications, diagnosis, management, self-care practice such as following a dietary regimen, physical exercise, drug regimen with insulin, and postnatal management. Health education were for the women, and their families. Modules for education included power point, lectures, and brochures that contained pictures for self-measuring of random blood glucose level, dietary recommendations to maintain blood sugar within the normal range, drug regimen.

Routine pre-natal care

Statistically significantly higher proportions of women had satisfactory knowledge in the study group compared to the control group. 

 

Significantly more women were satisfied with their knowledge about gestational diabetes after the intervention in the study group was than in the control group. 

 

Significantly higher proportions of favourable practices were found in the study group compared to the control group. 

 

Significantly more women had more total favourable self-care practices after the intervention in the study group than in the control group.

 

Statistically significantly higher proportions of complications in the control group than the study group were found.

 

The rate of normal delivery was higher in the study group, and the rate of caesarean section was higher in the control group.

 

The rates of foetal health problems were significantly higher in the control group than the study group e.g., jaundice, macrosomia etc.

                     –

                     –

19

#Yu et al., 201449

High risk

Continuous glucose monitoring (CGM) PLUS standard antenatal care. 

 

Visits included downloads and analysis of data in meter and sensor (only for patients in CGM group), nutrition consultation, education of information on blood glucose testing and self-care activities, and getting an individualized diabetes care prescription, which was arranged by the same obstetric diabetes team. 

Standard antenatal care using intermittent SMBG test from capillary

blood obtained by the finger prick technique.

 

Visits included nutrition consultation, education of information on blood glucose testing and self-care activities, and getting an individualized diabetes care prescription, which was arranged by the same obstetric diabetes team.

Better glycaemic control and improved pregnancy outcomes in the CGM group by reducing the risk of pre-eclampsia and caesarean delivery, decreasing the birth weight, and improving neonatal complications.

 

 

 

 

                  –

                  –

20

++Sunsaneevithayakul et al., 200438

High risk

#Prescribed intensive diet therapy for 3 days. received extensive dietary counseling by a well-trained diabetes nurse educator and physicians. The diabetic counseling and teaching, as well as the obstetric management, were done during admission.

#Standard treatment of all subjects involved diabetes education, control of hyperglycemia, with fetal and maternal surveillance. Daily caloric assignment was calculated based on ideal body weight, 30-35 Kcal/kg.

Short course of intensive dietary therapy during the 3 days of admission enabled good glycemic control such that 57·4% did not require insulin therapy. 

                     –

                     –

21

Artal et al., 200746

High risk

Exercise and diet. Exercise was equivalent to a 60% symptom-limited VO2 max.

Diet alone

Maternal weight gain per week was significantly lower in the exercise and diet group. 

                  –

Other pregnancy and foetal outcomes such as complications, gestational age at delivery, and rate of caesarean delivery were similar in both groups. 

22*

*Kgosidialwa, et al., 201547

High risk

*Diet and exercise. Each patient received an hour-long, individual consultation with a dietician at time of GDM diagnosis and additional consultations were arranged if deemed necessary. Exercise was

tailored to the individual woman basing on the American Congress of Obstetrics and Gynaecology. In addition, women had access to a phone service to contact the midwife/diabetes nurse specialist during office hours for advice. Women were advised to monitor their blood glucose levels

using a glucometer (capillary glucose monitoring) at least 7 times a day (premeal, 1-hour post meals, and at bedtime). Blood glucose targets were set at 5·3 mmol/L for fasting/premeal glucose levels and 7·8 mmol/L 1 hour post meals.

*Women with normal glucose tolerance – received routine antenatal care

 

 

 

 

*LGA and macrosomia

rates were lower in the MNT and exercise treated GDM group compared with the NGT group.

                     –

All other adverse outcomes were similar between groups. 

23

*$Wang et al., 201545

High risk

$Exercise intervention

Exercise intervention means sit less, take more steps, be

more active, incorporate light and moderate physical activity as much as possible into their daily life et al., and diet intervention means reduce intake of sugar, eat more vegetables, reduce fat intake, and the total energy intake 1800 calories a day in all.

$Women without GDM PLUS women with GDM without exercise intervention

Women with GDM with exercise intervention (GDM-E) had the lowest BMI increase during late and mid-pregnancy than women with GDM without exercise

intervention (GDM-nE) (2·05 ± 1·32 kg/m2 vs. 2·40 ± 1·30 kg/m2, p < 0·01) and non-GDM women (2·05 ± 1·32 kg/m2 vs 2·77 ± 1·21 kg/m2, p < 0·01).

 

Moreover, GDM-E group experienced a significantly lower risk of preterm birth (5·58 % vs. 7·98 %, p < 0·001), low birth weight (1·03 % vs. 2·06 %, p < 0·001) and macrosomia (9·51 % vs. 11·18 %, p < 0·05) than GDM-nE group.

 

Women with GDM with both dietary and exercise intervention had the lowest rate of macrosomia.

                  –

                  –

24

*Shi et al., 201639

High risk

Pregnant women with GDM were routinely advised to receive MNT counselling where trained nutritionists provide individualized MNT programs for pregnant women with confirmed GDM. They also established daily energy requirements and calorie supply proportions of the three major nutrients in accordance with the China Medical Nutrition Therapy

Guideline for Diabetes (2010) based on the pre-pregnancy body type,

gestational age at the time of GDM diagnosis, increase in body weight during pregnancy, blood pressure, and lipid outcomes. They then provided suggestions with regard to the type of food, specifically quantifying the recommended intake for each type of food. They also assisted in the selection of foods among similar food types via the “method of food exchange serving” to diversify the patients' diets while ensuring a balanced intake of all necessary nutrients. Finally, they suggested reasonably arranged meal times and foods in each meal based on blood glucose monitoring data,

recommended staple foods with low glycemic index values, and emphasized eating many small meals to reduce each meal's glycemic load. Regular postprandial exercise was also recommended. Pregnant women were encouraged to obtain private fast blood glucose meters, kitchen scales, and body weight scales for self-monitoring of finger-prick blood glucose, food intake, and body weight at home.

No MNT 

The fasting plasma glucose, 2-hour blood glucose, and weight gain at 28 weeks, 32 weeks, and 36 weeks as well as intrapartum were lower in the MNT group than in the non-MNT group. 

 

Total weight gain during pregnancy and the rates of adverse events during pregnancy were lower in the MNT group compared to the non-MNT group (all p < 0.05). 

 

Moreover, 92·2% of the participants in the MNT group had a normal oral glucose tolerance test result, and the rate of exclusive breastfeeding within 4 months after delivery was 54·4% in the MNT group; both were higher than those of the non-MNT group (66·3%, p < 0·001; 29·3%, p < 0·05).

                     –

                  –

25

Perichart-Pereraet al., 200940

High risk

Intensive MNT programme

The MNT program consisted of individual nutrition counseling with an intensive education component performed

by one clinical dietitian. The program included

nutrition assessment, nutrition intervention, and capillary glucose self-monitoring. Specific materials were designed

for nutrition therapy and self-monitoring education.

Nutrition recommendations were based on nutrition practice guidelines for gestational diabetes developed and published by the American Dietetic Association. Women received a glucose meter (Optium MediSense, Abbott Laboratories, Bedford, MA) and strips to perform capillary blood glucose self-monitoring 2 days a week, 6 times a day (before and 2 hours after each meal). Fasting and 2 hours postprandial serum glucose was also measured

every 2 weeks by a glucose oxidase method. Until the end of pregnancy, all women received follow-up every 2 weeks by the dietitian and the endocrinologist, who was responsible for prescribing insulin, as needed, to meet

glycaemic goals.

Routine antenatal care in a historical control.

Usual routine care in the control group included monthly medical visits with the endocrinologist before 28 weeks of gestation, and every 2 weeks thereafter. Most women attended 1 initial nutrition orientation group session where they received dietary information from a

technician. Less than 5% of them had a glucose meter to

perform capillary glucose self-monitoring

Serum 2 hours postprandial glucose values during the

last visit tended to be lower in women in the MNT programme compared with women in the control group (107·05 ± 23·83 vs 115·64 ± 36·11).

 

The number of total perinatal complications was higher in the control group than the MNT programme (P = 0·005). 

 

Fewer women

in the MNT programme (27·3%) had ≥1 perinatal complications,

than the control group (45·3%, P = 0·013).

 

Fewer women developed

preeclampsia in the MNT programme than the control group (2·3% vs 16·3%; P = 0·001). 

 

First maternal hospitalization

(due to uncontrolled hyperglycemia) was less frequent in the MNT programme (5·7% vs 62·8%; P < 0·001).

 

Moreover, women in the MNT programme did not require a second hospitalization. 

 

 

No neonatal deaths and lower NICU admissions were also observed in the MNT programme (P = 0·001).

                  –

Among women with gestational diabetes, more women in

the control group used insulin than women in the MNT programme (56·4% vs 35·9%) but the doses prescribed were not statistically different (16 vs 0 unit/day, P = 0·052).

 

Fasting glucose values were not different between women in the MNT programme and the women in the control group.

 

Although there were no statistically significant differences, a greater proportion of women in the control group had elevated values of serum fasting

and 2 hours postprandial glucose levels (fasting: 37·2% vs 33·0%, P = 0·715; 2 hours postprandial: 37·2% vs 26·1%,

P = 0·169).

 

 

Although the frequency of prematurity, macrosomia, and low birth weight were not statistically different among the

groups, the MNT programme showed lower rates. 

 

Intrauterine death was similar between the 2 groups.

26

Murphy et al., 200441

High risk

Nutrition counselling for patients with gestational diabetes mellitus (GDM) in small group.

 

Nutrition counselling, provided by a registered dietitian, consisted of a 1-hour interactive education session using a tabletop flip chart. Supporting written materials were used in both categories

to reinforce the topics discussed. Subjects completed a knowledge assessment test based on the content of the counselling session, which consisted of 12 multiple choice questions, at 3 time points: prior to nutrition counselling, immediately after counselling and 1 week after counselling.

Nutrition counselling for patients with gestational diabetes mellitus (GDM) in individual counselling.

 

Nutrition counselling, provided by a registered dietitian, consisted of a 1-hour interactive education session using a tabletop flip chart. Supporting written materials were used in both categories to reinforce the topics discussed. Subjects completed a knowledge assessment test based on the content of the counselling session, which consisted of 12 multiple-choice questions, at 3 time points: prior to nutrition counselling, immediately after counselling and 1 week after counselling.

A total of 27 dietitian hours were saved with small-group counselling.

 

Women with GDM can be effectively and cost-efficiently counselled on nutrition in small-group settings.

                     –

Post counselling results showed a significant improvement in knowledge,

regardless of counselling method (p<0·0001).

 

Post counselling

results showed no difference in knowledge improvement

between participants in small-group counselling and those who received individual counselling, based on equivalence testing (95% confidence interval [CI]: -3·7 to 5·5).

 

One-week follow-up results demonstrated that knowledge was retained in both counselling categories (95% CI: -6·2 to 2·4).

++27

++Hayashi et al., 20184

High risk

++Daily walking for GDM

management.

 

The total amount of daily walking was estimated from the number of steps taken and the amount of exercise performed daily, as measured with an accelerometer Participants attached the accelerometer to the waistbands of their skirts or pants, as instructed at the time of recruitment by investigators. The accelerometers assessed daily

walking for a total of 7–12 weeks because periodic

pregnancy examinations were performed every 4 weeks on the basis of the number of steps taken and the amount of exercise performed every day from the

second trimester to the third trimester. The accelerometers

were removed during sleeping and bathing. In the third trimester, the participants removed the accelerometers

permanently and completed questionnaires that assessed dietary intake.

++No control group

++Simple walking for light intensity physical activity is effective for controlling the CGL in pregnant women with GDM.

 

++There was a significant negative correlation (r = −0·603, P = 0·014) between the post- to pre-research casual glucose level (CGL) ratio and the number of steps walked daily. 

 

 

When the study was completed, the 11 participants who walked ≥6000 steps/day showed significantly lower CGL (95 + 10 mg/dL [mean + SD]) than the 13 participants in the <6000 steps/day group (111 + 18 mg/dL) (P = 0·013).

 

++No significant correlation (r = −0·004, P = 0·986) was detected between the

ratio of hemoglobin A1c and the number of steps taken. 

 

*: retrospective cohort study with control; #:prospective cohort study with control; ++: longitudinal study4 or case series38 without control group, participants served as their own controls; LGI diet: low–glycaemic index diet; GI: glycaemic index; HF: high fibre; EG: exercise group; CG: control group; BG: blood glucose; CIT: Cell phone–Internet Technology; SMBG: self-monitoring of blood glucose; GDM: gestational diabetes mellitus; HBM: health belief model; HbA1c: glycated haemoglobin; CGM: continuous glucose monitoring; $: not a proper control group because experimental and control groups were different populations; MNT: medical nutrition therapy; LGA: large for gestational age; NGT: normal glucose tolerance; CGL: casual glucose level.

Summary of individual study outcomes 

Majority (25) of the studies showed that community-based non-pharmacological interventions were more effective than control interventions which included routine/standard prenatal care, placebo, or no treatment in improving the greatest number of maternal and new-born outcomes. 15 studies reported similar effectiveness in comparatively fewer number of outcomes in the intervention and control groups. Only one study reported a superior improvement in a neonatal outcome (neonatal body mass index), and only one study reported a superior improvement in a maternal outcome (reduced caesarean section use), both when compared with control (routine/standard prenatal care). 

Summary of community-based non-pharmacological interventions

1. Self-management programmes

Nine studies investigated self-management programmes which involved face-to-face educational sessions and self-care guide package22, health education and lifestyle management delivered using social media (WeChat) plus motivational briefing to promote self-care in relation to diet, exercise, and blood glucose control23, self-management education programme involving goal setting, motivational interviewing to increase self-efficacy, social support, self-monitoring of blood glucose, plus phone call reminder of education24, self-efficacy enhancing intervention involving individualised health education comprising motivational messages, role modelling, goal-setting and mastery experience to facilitate healthy behaviours25, cell phone–internet technology (CIT) for self-management (monitoring) of hyperglycemia during pregnancy26, supplementary 1-hour education session for diabetes education27, health-promoting lifestyle education programme28, continuous health education using a smartphone-based telemedicine system29, group educational programme enhancing health-related knowledge and facilitating self-care30

2. Medical nutrition/diet therapy interventions

Nine studies examined medical nutrition/diet therapy programmes which involved low–glycaemic index (LGI) diet31–33, oat bran plus routine diet for gestational diabetes34, dietary approaches to stop hypertension (DASH) diet that is rich in fruits, vegetables, whole grains and low-fat diary products35, 3-day intensive diet therapy36, medical nutrition therapy counselling37–39.   

3. Exercise/physical activity programmes

Five studies investigated exercise/physical activity programmes which involved resistance exercise40, regular supervised exercise plus daily brisk walking41, aerobic dance exercise42, physical activity lifestyle programme43, and daily walking programme4

4. Combined diet and exercise interventions

Two studies investigated combined exercise and diet therapy programmes which involved exercise equivalent to a 60% symptom-limited VO2 max and diabetic diet44, and consultation with a dietician plus individually tailored exercise45.

5. Calcium and vitamin D supplement therapy

One study examined the use of combined 1000 mg of Calcium and two pearls containing 1250 μg (50 000 IU) of cholecalciferol46.  

6. Continuous glucose monitoring intervention

One study investigated the use of continuous glucose monitoring which involved the use of continuous glucose monitoring system to assess 24-hour glucose fluctuations (every 10 seconds and an average value stored every 5 minutes. This provides up to 288 measurements per day, and offers a complete view of glucose profile about the direction, magnitude, duration, frequency, and causes of fluctuations in blood glucose levels47

Results of syntheses 

Effectiveness of community-based non-pharmacological interventions 

Meta-analysis was precluded due to different intervention content in experimental and control groups, study designs, and outcomes (Tables 2 and 4).  

Effectiveness of self-management programmes

Self-management programmes consistently improved most health behaviour-related outcomes such as self-efficacy22,24,25, lifestyle behaviours25,28, self-management behaviour24, self-monitoring of blood glucose26, adherence to recommended healthy health promoting behaviours27, cues to action24, perceived benefits24, perceived barriers24, perceived severity24, perceived susceptibility24, and satisfactory knowledge30 better than routine obstetric care. 

Two-hour postprandial blood glucose was also consistently better improved by self-management programmes than routine care22,26,29

Only one clinical trial each measured quality of life28 and satisfaction26, pregnancy-induced hypertension29 with all reporting better improvements in the self-management programmes. 

No differences between self-management programmes and routine care were found for infant birth weight22,23 and age of neonate at delivery22, premature rupture of membranes23,  postpartum haemorrhage23, days of maternal/neonatal hospitalisation27.

Other maternal and neonatal clinical outcomes were conflicting. Two clinical trials (one cross-over trial) reported no difference in fasting blood glucose in the routine care and self-management programmes22,26; but one non-RCT reported superior improvements in fasting blood glucose in the self-management programmes than routine care29. One study each reported superior effects of self-management programmes on blood glucose control (glycaemic qualification rate)23, glycated haemoglobin24, but another study reported no significant differences in glycaemic control27 compared with routine care. No differences were found in macrosomia27 in one study whereas another study reported lower rates of macrosomia in the self-management programmes compared with routine care28. One study reported no differences in preterm birth23 but another study showed lower rates of premature delivery in the self-management programme compared with routine care29. Two studies reported no differences in the type of delivery22,23, whereas one study reported that caesarean section was less in the routine care group compared with self-management29

Effectiveness of medical nutrition/diet therapy interventions

Medical nutrition/diet therapy interventions consistently improved postprandial blood glucose levels more than routine diabetic diet32–34,37,38

One study showed that small group nutritional counselling saved 27 dietitian hours compared to individual nutritional counselling, with knowledge levels being similar in both treatment groups39

Fasting blood glucose was better improved by the addition of 30 grams oat bran daily to routine diabetic diet for 4 weeks than routine diabetic diet alone34. Superior improvements in fasting blood glucose was produced by a medical nutrition therapy (MNT) counselling compared with a no MNT group37. Another MNT programme produced similar improvements in fasting blood glucose as routine obstetric care38

Similar glycaemic control was observed between a low glycaemic index diet and a routine diabetic diet consisting of conventional high fibre diet 32. However, a three-day intensive diet therapy produced superior glycaemic control than routine diabetic care such that fewer people required insulin therapy36

Similar outcomes between a low glycaemic index and a conventional high fibre diet were produced for infant birth weight, ponderal index (within normal), maternal weight, foetal abdominal circumference34. Likewise, similar outcomes were produced by an intensive MNT programme and routine obstetric care in insulin use, prematurity, macrosomia, low birth weight, and intrauterine death38. MNT counselling produced superior outcomes in maternal weight, rates of adverse events, and exclusive breast feeding than a no MNT control37. Similarly, an intensive MNT programme produced better outcomes in rates of perinatal complications, preeclampsia, maternal hospitalisations, neonatal intensive care unit admissions, and had no neonatal deaths compared with routine obstetric care38. Dietary approaches to stop hypertension (DASH) diet that is rich in fruits, vegetables, whole grains and low-fat diary products produced superior pregnancy outcomes (lower caesarean delivery and insulin therapy), lower rates of macrosomia, lower birth weight and head circumference, and lower ponderal index; but similar outcomes in gestational age, polyhydramnios, newborn length, and Apgar score compared to a control diet (45-55% carbohydrate, 15-20% protein, 25-30% total fat) given as routine care35

Effectiveness of exercise/physical activity programmes

Postprandial blood glucose levels were better improved by regular supervised exercise plus daily brisk walks than routine obstetric care41. Similarly, postprandial blood glucose levels were improved by a daily walking intervention in a pre-post-test study with no control group4. The effects of exercise/physical activity programmes were mostly inconsistent for other outcomes.

Fasting blood glucose was better improved by an aerobic dance exercise intervention than routine obstetric care42. In contrast, a regular supervised exercise plus daily brisk walking intervention and routine obstetric care produced similar improvements in fasting blood glucose41. Resistance exercise produced greater improvements in glycaemic control (weeks within target blood glucose range) than routine obstetric care but resistance exercise and routine obstetric care produced similar mean glucose levels40

Resistance exercise produced greater reduction in people requiring insulin, new-born birthweight but similar outcomes in quantity of insulin required by patients, time interval between patient inclusion in study and insulin use, rates of caesarean section, rates of preterm when compared with routine obstetric care40. Physical activity lifestyle programme produced better improvements in maternal body mass index, rates of preterm birth, rates of low birth weight, and macrosomia than a control group without such intervention43. Regular supervised exercise plus daily brisk walks produced similar outcomes as routine obstetric care on rates of pregnancy and birth complications, need for pharmacological therapy, maternal body mass and body fat percentage, neonatal Apgar scores, ponderal index. However, neonatal body mass index was better in the routine obstetric care group than the exercise/physical activity group41

Effectiveness of combined diet and exercise interventions

Diet and exercise was superior to diet alone in reducing maternal weight gain per week but similar outcomes were observed for other pregnancy and foetal outcomes including complications, gestational age at delivery, and rate of caesarean delivery44. Diet and exercise were better in improving the rates of large for gestational age and macrosomia compared with pregnant women with normal glucose tolerance placed on routine obstetric care, although other adverse outcomes were similar between the two groups45

Effectiveness of calcium and vitamin D supplement therapy

Significant decrease in the rates of caesarean delivery, maternal hospitalisation, hyperbilirubinaemia, newborn hospitalisation were observed with combined 1000 mg of Calcium and 1250 μg of cholecalciferol compared with placebo. No case of macrosomia was seen with the vitamin supplementation, in contrast to placebo46

Effectiveness of continuous glucose monitoring intervention

Better glycaemic control, reduced risk of pre-eclampsia and caesarean delivery, and reduced birth weight and neonatal complications were produced with continuous glucose monitoring plus routine obstetric care compared to routine obstetric care alone47.

Reporting bias in overall results

There were no systematic differences in the consistent and inconsistent outcomes based on study rating of bias, study design and the size of individual studies.

Certainty of overall results

Strong evidence showed that the community-based self-management programmes improved self-efficacy22,24,25, and 2-hour postprandial blood glucose22,26,29, better than routine care. Moderate evidence suggests that the self-management programmes improved life style behaviours25,28, better than routine care. Moderate evidence indicated that the self-management programmes produced similar outcomes on infant birth weight as routine care22,23

The strength of evidence for the effectiveness of the self-management programmes for some outcomes was conflicting.  Moderate evidence suggests that the self-management programmes produced similar outcomes as routine care for fasting blood glucose22,26 but very low evidence suggest that they are superior to routine care29 for fasting blood glucose. There is very low evidence that the self-management programmes were superior or as effective as routine care in improving blood glucose control24,27, macrosomia27,28, and preterm delivery23,29. There is moderate evidence that the self-management programmes produced similar outcomes as routine care in reducing the rates of caesarean delivery22,23, but very low strength of evidence that they are inferior to routine care29 in reducing the rates of caesarean delivery.

There is moderate evidence that community-based medical nutrition/diet therapy interventions were more effective than usual care in improving postprandial blood glucose levels32–34,37,38

The strength of evidence for the other outcomes and the effectiveness of the other community-based non-pharmacological interventions was uncertain because only one study examined them. 

Discussion

Community-based interventions can be diverse since ‘community’ can be conceptualised as the setting, target, agent, or the resource48. This first systematic review of community-based non-pharmacological interventions indicate that they were more effective than routine care in improving health behaviour related outcomes and two-hour postprandial blood glucose. Other outcomes of these programmes were less consistent. Community-based self-management programmes were superior to or as effective as routine care in improving fasting blood glucose, blood glucose control, glycated haemoglobin, macrosomia/infant birth weight, and preterm delivery. There was a trend towards community-based self-management programmes being superior to routine care in improving self-management behaviour, self-monitoring of blood glucose, adherence to recommended health promoting behaviours, quality of life, satisfaction, pregnancy-induced hypertension, cues to action, perceived benefits, perceived barriers, perceived severity, perceived susceptibility, and satisfactory knowledge. However, there was a trend towards the self-management programmes being similar to usual care in improving age of neonate at delivery, premature rupture of membranes, postpartum haemorrhage, and days of maternal and neonatal hospitalisation. The impact on the rates of caesarean delivery is conflicting.

These findings align with the reviews of self-management programmes for other diabetic populations including adults, adolescents and/or children with type 1 or type 2 diabetes mellitus. Self-management programmes were efficacious and cost effective for facilitation of self-management, improvements in patients' knowledge, skills, and motivation, and improved biomedical, behavioural, and psychosocial outcomes49. Self-management programmes had a greater impact on glycaemic outcomes than on mental health outcomes which were rarely assessed50. Blood glucose control, diabetes knowledge, body weight, blood pressure, low density lipoprotein cholesterol, mean arterial pressure, anxiety and depression, diabetes distress, sedentary behaviours, quality of life, self-efficacy, self-care, self-management skills, and treatment satisfaction were improved following diabetes self-management programmes51. Self-management produced better improvements in glycated haemoglobin, diabetes knowledge, self-efficacy, self-management behaviours, depression, quality of life and patient satisfaction compared with routine care52. Self-management programmes were better than routine care for fasting blood glucose, blood pressure, body mass index, self-efficacy, diabetes knowledge; but were similar for self-management practices, physical activity, diabetes distress, and depression53.

The conflicting results of the impact of self-management programmes for some outcomes in our review could be due to the different content, intensity, and delivery of the self-management programmes in few studies. Other reviews of diabetes self-management programmes have made similar observations and reported very few and differing studies of diverse diabetes self-management programmes which make interpretation and generalisation of findings difficult51,53. The recommendation that diabetes self-management programmes be tailored acknowledging individual and cultural needs54 might increase effectiveness and consistency of findings. Determining and utilising active components and core outcomes of diabetes self-management programmes could enhance effectiveness and consistency of findings. Self-management programmes focus on lifestyle changes, health behaviour change, and daily self-management of conditions5558 which could explain the consistent superior effectiveness of the community-based self-management programmes on health behaviour related outcomes when compared with routine care in our review.

Our results show that community-based medical nutrition/diet therapy interventions were more effective than routine care in improving postprandial blood glucose levels; which can be a proxy for good adherence to nutritional therapy59. The effectiveness of the interventions was less certain for the other outcomes because only one study reported each of them. Overall, there was a trend towards community-based medical nutrition/diet therapy interventions being superior to or as effective as usual care in the other maternal outcomes and all neonatal outcomes. Intensive nutritional interventions tended to be more effective than usual care in the greatest number of outcomes. Although group nutritional counselling was as effective as individual nutritional counselling in improving diabetes knowledge, group counselling had an additional advantage of saving dietitian hours.

Overall, our review found no evidence that any specific community-based nutritional therapy was superior to the other. This could be because any diet based on low glycaemic index diet, high in complex carbohydrate and fibre, low in simple sugar and low in saturated fat produce positive outcomes in GDM including reduction in blood glucose, prevention of insulin resistance, and attenuating excess foetal fat accretion5964. Low glycaemic index diet is known to reduce two hour post prandial glucose, fasting blood glucose, and lipid profile in patients with GDM65. This aligns with our review which found that glycaemic control was similar between low glycaemic index and conventional high fibre diets. Low carbohydrate diet is not better than high complex carbohydrate diet66. Low carbohydrate diet can stimulate higher fat intake exacerbating maternal insulin resistance due to increased free fatty acids64,67,68. High fibre and low-fat intake increase gut microbiota diversity and richness which reduce insulin resistance and inflammatory response69. Caloric restriction is generally advised only for overweight and obese pregnant women with GDM59,60. However, there is no consensus on specific diet characteristics including carbohydrate distribution and quantity due to the limited number of high quality clinical trials and the complexity that such interventions and studies will warrant59,60,64,70.

The strength of evidence for the effectiveness of community-based exercise/physical activity was limited due to the paucity of studies (less than two studies for each outcome). There was a trend for physical activity/exercise interventions being superior in improving postprandial blood glucose levels than routine care and no treatment. Other outcomes were less consistent but overall physical activity/exercise interventions tended to be better than or as effective as routine care in improving fasting blood glucose, glycaemic control, mean glucose levels, proportion requiring insulin, quantity of insulin required, time to insulin use, new-born birthweight, rates of caesarean section, rates of preterm birth, maternal body mass index, rates of low birth weight, macrosomia, rates of pregnancy and birth complications, need for pharmacological therapy, maternal body mass and body fat percentage, neonatal Apgar scores, ponderal index. Neonatal body mass index was the only outcome reported to be better with routine obstetric care in one study. There is limited direct evidence with which to compare these findings. A systematic review which shows that physical activity during pregnancy improves fasting and postprandial glucose, as well as glycated haemoglobin in pregnant women with GDM, had four of the included six studies combining exercise with diet71.

Most reviews have focused on the prevention of GDM using exercise/physical activity. Although previous reviews found insufficient evidence that exercise/physical activity during pregnancy is effective in reducing the development of GDM72,73, more recent systematic reviews have found that exercise during pregnancy reduces the risk of developing GDM7476. The greatest benefit of physical activity in reducing the risk of GDM occurs before pregnancy77. Findings from our review and previous reviews have not shown any evidence for the superiority of any exercise type. However, guidelines recommend both aerobic and resistance exercise at a moderate intensity, a minimum of three times per week for 30–60 minutes each time78. The exercise/physical activity interventions in our review were aerobic, resistance, or combined aerobic and resistance exercise which may align with this recommendation. Exercise/physical activity provides an alternative pathway of glucose uptake to insulin activated transport via muscular contraction that ultimately stimulates glucose transport; directly increases the biogenesis of GLUT4 which is an insulin-regulated glucose transporter that is responsible for insulin-regulated glucose uptake into fat and muscle cells; and can strengthen and compensate for defects in insulin signalling; which improve glycaemic control79.

Our review found very limited evidence that community-based diet and exercise was better than diet alone or routine obstetric care in improving maternal and neonatal outcomes particularly maternal and neonatal weight. Evidence suggest that dietary improvements and physical activity are effective in managing hyperglycaemia and the associated sequelae80.

Similarly, our review found very limited evidence that combined calcium and vitamin D supplement therapy was better than placebo in reducing the rates of caesarean delivery, maternal hospitalisation, hyperbilirubinaemia, newborn hospitalisation, and preventing macrosomia. Evidence suggests that multivitamins containing vitamin D reduce the risk of preeclampsia which was not found with administering only vitamins C and E60,81. There is some evidence that vitamin D supplements improve insulin sensitivity in women with GDM, and an intake of 900-1000mg of calcium per day is recommended for all pregnant women60,81. Calcium is considered important because the hyperglycaemia resulting from GDM is associated with neonatal hypocalcaemia, hypoglycaemia, hyperbilirubinemia, polycythaemia and respiratory distress syndrome82.

We found very limited evidence that continuous glucose monitoring added to routine obstetric care reduced risk of pre-eclampsia and caesarean delivery, and reduced birth weight and neonatal complications better than routine obstetric care only. A recent meta-analysis of six RCTs found that continuous glucose monitoring was associated with lower glycated haemoglobin, less gestational weight gain, lower birth weight compared to standard blood glucose monitoring. However, there were no differences between continuous glucose monitoring and standard blood glucose monitoring for gestational age newborns, gestational age at birth, preterm deliveries, shoulder dystocia, neonatal hypoglycaemia, Apgar at five minutes, admission to neonatal intensive care unit, neonatal jaundice, and neonatal mortality83.

Conclusions

Community-based non-pharmacological interventions were more effective or as effective as routine obstetric care in improving the most maternal and neonatal outcomes; and could be delivered by a broad range of health professionals. Of the six interventions identified, self-management programmes and medical nutrition/diet therapy had the strongest evidence for the most promising outcomes – on postprandial blood glucose levels and health behaviour related outcomes. There is need for more research on the effectiveness of these interventions whilst focusing on core GDM outcomes84 and the active components of these interventions. There may be need to compare the clinical and cost-effectiveness of these interventions with hospital-based interventions.

Abbreviations

GDM: Gestational Diabetes Mellitus. 

PRISMA: Preferred Reporting Items for Systematic reviews and Meta-Analyses.

SWiM: Synthesis without meta-analysis in systematic reviews.

MeSH: Medical Subject Heading.

RCT: Randomised Controlled Trial.

CIT: Cell phone–Internet Technology. 

LGI: Low–Glycaemic Index.

DASH: Dietary Approaches to Stop Hypertension.

MNT: Medical Nutrition Therapy.

Declarations

Ethics approval and consent to participate 

Not applicable.  

Consent for publication

Not applicable. 

Availability of data and materials 

The review protocol is freely available on PROSPERO. Further information can be obtained via request to the corresponding author. 

Competing interests

The authors declare that they have no competing interests.

Funding

There was no funding for this study. The study design, data collection, data analysis and interpretation, and writing of this manuscript were not influenced externally by any funder.   

Authors’ contributions

CNI-C conceptualised the study, developed the review protocol, synthesized and interpreted results, coordinated all review activities, and wrote the article. PCO and GNE collaborated on database searching, screening, data extraction, and quality appraisal. PCO contributed to result synthesis and writing the article. All authors critically revised the article for intellectual content and approved the final version. All authors had full access to all study data and jointly made the decision to submit the manuscript for publication.

Acknowledgements

Not applicable. 

References

  1. Craig L, Sims R, Glasziou P, Thomas R. Women’s experiences of a diagnosis of gestational diabetes mellitus: a systematic review. BMC Pregnancy Childbirth. 2020;20(1):1–15.
  2. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Prim. 2019;5(1):1–19.
  3. Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016;59(7):1396–9.
  4. Hayashi A, Oguchi H, Kozawa Y, Ban Y, Shinoda J, Suganuma N. Daily walking is effective for the management of pregnant women with gestational diabetes mellitus. J Obstet Gynaecol Res. 2018;44(9):1731–8.
  5. Dirar AM, Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017;8(12):489.
  6. Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016;16(1):1–11.
  7. Di Guardo F, Currò JM, Valenti G, Rossetti P, Di Gregorio LM, Conway F, et al. Non-pharmacological management of gestational diabetes: The role of myo-inositol. J Complement Integr Med. 2020;17(2).
  8. Guo X, Shu J, Fu X, Chen X, Zhang L, Ji M, et al. Improving the effectiveness of lifestyle interventions for gestational diabetes prevention: a meta‐analysis and meta‐regression. BJOG An Int J Obstet Gynaecol. 2019;126(3):311–20.
  9. Gilbert L, Gross J, Lanzi S, Quansah DY, Puder J, Horsch A. How diet, physical activity and psychosocial well-being interact in women with gestational diabetes mellitus: an integrative review. BMC Pregnancy Childbirth. 2019;19(1):1–16.
  10. Moisés ECD. Multidisciplinary Care of Pregnant Women with Gestational Diabetes Mellitus: Non-Pharmacological Strategies to Improve Maternal and Perinatal Outcomes. Gestation Diabetes-Causes, Diagnosis Treat. 2013;17.
  11. Mariani HS, Layden BT, Aleppo G. Continuous glucose monitoring: a perspective on its past, present, and future applications for diabetes management. Clin Diabetes. 2017;35(1):60–5.
  12. Nielsen KK, de Courten M, Kapur A. Health system and societal barriers for gestational diabetes mellitus (GDM) services-lessons from World Diabetes Foundation supported GDM projects. BMC Int Health Hum Rights. 2012;12(1):1–10.
  13. Kolu P, Raitanen J, Rissanen P, Luoto R. Health care costs associated with gestational diabetes mellitus among high-risk women–results from a randomised trial. BMC Pregnancy Childbirth. 2012;12(1):1–8.
  14. Murphy JW. Community-based interventions: Philosophy and action. Springer; 2014.
  15. Igwesi-Chidobe CN, Emmanuel GN, Okezue OC. Community-based non-pharmacological interventions for improving pain, disability and quality of life in pregnant women with musculoskeletal conditions: protocol for a systematic review with meta-analyses. BMJ Open. 2021;11(2):e042107.
  16. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. bmj. 2021;372.
  17. Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. bmj. 2020;368.
  18. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019.
  19. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372.
  20. Cochrane Consumers and Communication Review Group. data extraction template for Cochrane reviews. Cochrane Collaboration; 2016.
  21. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.
  22. Kolivand M, Rahimi MA, Keramat A, Shariati M, Emamian MH. Effect of a new self‐care guide package on maternal and neonatal outcomes in gestational diabetes: A randomized control trial. J Diabetes. 2019;11(2):139–47.
  23. Tian Y, Zhang S, Huang F, Ma L. Comparing the Efficacies of Telemedicine and Standard Prenatal Care on Blood Glucose Control in Women With Gestational Diabetes Mellitus: Randomized Controlled Trial. JMIR mHealth uHealth. 2021;9(5):e22881.
  24. Mohebbi B, Tol A, Sadeghi R, Mohtarami SF, Shamshiri A. Self-management Intervention Program Based on the Health Belief Model (HBM) among Women with Gestational Diabetes Mellitus: A Quazi-Experimental Study. Arch Iran Med. 2019;22(4).
  25. Al-Hashmi I, Hodge F, Nandy K, Thomas E, Brecht M-L. The effect of a self-efficacy-enhancing intervention on perceived self-efficacy and actual adherence to healthy behaviours among women with gestational diabetes mellitus. Sultan Qaboos Univ Med J. 2018;18(4):e513.
  26. Bartholomew ML, Soules K, Church K, Shaha S, Burlingame J, Graham G, et al. Managing diabetes in pregnancy using cell phone/internet technology. Clin Diabetes. 2015;33(4):169–74.
  27. Mendelson SG, Mcneese-Smith D, Koniak-Griffin D, Nyamathi A, Lu MC. A community-based parish nurse intervention program for Mexican American Women with gestational diabetes. JOGNN - J Obstet Gynecol Neonatal Nurs. 2008;37(4):415–25.
  28. Ural A, Kizilkaya Beji N. The effect of health-promoting lifestyle education program provided to women with gestational diabetes mellitus on maternal and neonatal health: a randomized controlled trial. Psychol Health Med. 2021;26(6):657–70.
  29. Yang P, Lo W, He Z, Xiao X. Medical nutrition treatment of women with gestational diabetes mellitus by a telemedicine system based on smartphones. J Obstet Gynaecol Res. 2018;44(7):1228–34.
  30. Sayed Ibrahim R El, Mousa Saber N. Impact of self-care program for gestational diabetic women on pregnancy outcomes. Am J Nurs Res. 2019;8(1):122–31.
  31. Louie JCY, Markovic TP, Perera N, Foote D, Petocz P, Ross GP, et al. A randomized controlled trial investigating the effects of a low–glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care. 2011;34(11):2341–6.
  32. Grant SM, Wolever TMS, O’Connor DL, Nisenbaum R, Josse RG. Effect of a low glycaemic index diet on blood glucose in women with gestational hyperglycaemia. Diabetes Res Clin Pract. 2011;91(1):15–22.
  33. Hu Z-G, Tan R-S, Jin D, Li W, Zhou X-Y. A low glycemic index staple diet reduces postprandial glucose values in Asian women with gestational diabetes mellitus. J Investig Med. 2014;62(8):975–9.
  34. Barati Z, Iravani M, Karandish M, Haghighizadeh MH, Masihi S. The effect of oat bran consumption on gestational diabetes: A randomized controlled clinical trial. BMC Endocr Disord. 2021;21(1):1–8.
  35. Asemi Z, Samimi M, Tabassi Z, Esmaillzadeh A. The effect of DASH diet on pregnancy outcomes in gestational diabetes: a randomized controlled clinical trial. Eur J Clin Nutr. 2014;68(4):490–5.
  36. Sunsaneevithayakul P, Ruangvutilert P, Sutanthavibul A, Kanokpongsakdi S, Boriboohirunsarn D, Raengpetch Y, et al. Effect of 3-day intensive dietary therapy during admission in women after diagnosis of gestational diabetes mellitus. JOURNAL-MEDICAL Assoc Thail. 2004;87(9):1022–8.
  37. Shi M, Liu Z-L, Steinmann P, Chen J, Chen C, Ma X-T, et al. Medical nutrition therapy for pregnant women with gestational diabetes mellitus—a retrospective cohort study. Taiwan J Obstet Gynecol. 2016;55(5):666–71.
  38. Perichart-Perera O, Balas-Nakash M, Parra-Covarrubias A, Rodriguez-Cano A, Ramirez-Torres A, Ortega-González C, et al. A medical nutrition therapy program improves perinatal outcomes in Mexican pregnant women with gestational diabetes and type 2 diabetes mellitus. Diabetes Educ. 2009;35(6):1004–13.
  39. Murphy A, Guilar A, Donat D. Nutrition education for women with newly diagnosed gestational diabetes mellitus: small-group vs. individual counselling. Can J diabetes. 2004;28(2):0.
  40. de Barros MC, Lopes MAB, Francisco RP V, Sapienza AD, Zugaib M. Resistance exercise and glycemic control in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2010;203(6):556-e1.
  41. Kokic IS, Ivanisevic M, Biolo G, Simunic B, Kokic T, Pisot R. Combination of a structured aerobic and resistance exercise improves glycaemic control in pregnant women diagnosed with gestational diabetes mellitus. A randomised controlled trial. Women and birth. 2018;31(4):e232–8.
  42. Daniel JA, Dikki CE. Aerobic dance exercise improves blood glucose level in pregnant women with gestational diabetes mellitus science. African J Phys Heal Educ Recreat Danc. 2014;20(21):273–81.
  43. Wang C, Zhu W, Wei Y, Feng H, Su R, Yang H. Exercise intervention during pregnancy can be used to manage weight gain and improve pregnancy outcomes in women with gestational diabetes mellitus. BMC Pregnancy Childbirth. 2015;15(1):1–8.
  44. Artal R, Catanzaro RB, Gavard JA, Mostello DJ, Friganza JC. A lifestyle intervention of weight-gain restriction: diet and exercise in obese women with gestational diabetes mellitus. Appl Physiol Nutr Metab. 2007;32(3):596–601.
  45. Kgosidialwa O, Egan AM, Carmody L, Kirwan B, Gunning P, Dunne FP. Treatment with diet and exercise for women with gestational diabetes mellitus diagnosed using IADPSG criteria. J Clin Endocrinol Metab. 2015;100(12):4629–36.
  46. Karamali M, Asemi Z, Ahmadi-Dastjerdi M, Esmaillzadeh A. Calcium plus vitamin D supplementation affects pregnancy outcomes in gestational diabetes: randomized, double-blind, placebo-controlled trial. Public Health Nutr [Internet]. 2016 Jan 1 [cited 2020 Jul 31];19(1):156–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25790761
  47. Yu F, Lv L, Liang Z, Wang Y, Wen J, Lin X, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab. 2014;99(12):4674–82.
  48. McLeroy KR, Norton BL, Kegler MC, Burdine JN, Sumaya C V. Community-based interventions. Am J Public Health. 2003;93(4):529–33.
  49. Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K. Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 2018;6(2):130–42.
  50. Hermanns N, Ehrmann D, Finke‐Groene K, Kulzer B. Trends in diabetes self‐management education: where are we coming from and where are we going? A narrative review. Diabet Med. 2020;37(3):436–47.
  51. Vas A, Devi ES, Vidyasagar S, Acharya R, Rau NR, George A, et al. Effectiveness of self‐management programmes in diabetes management: A systematic review. Int J Nurs Pract. 2017;23(5):e12571.
  52. Amagyei A, Meal A, Shaw I, Adams GG. Effectiveness of Community Health Worker-led Diabetes Self-Management Education on Type 2 diabetes patients: A Systematic Review and Meta-Analysis. Int J Diabetes. 2020;1(2).
  53. Werfalli M, Raubenheimer PJ, Engel M, Musekiwa A, Bobrow K, Peer N, et al. The effectiveness of peer and community health worker-led self-management support programs for improving diabetes health-related outcomes in adults in low-and-middle-income countries: a systematic review. Syst Rev. 2020;9(1):1–19.
  54. Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, et al. National standards for diabetes self-management education and support. Diabetes Care. 2014;37(Supplement_1):S144–53.
  55. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–87.
  56. Grady PA, Gough LL. Self-management: a comprehensive approach to management of chronic conditions. Am J Public Health. 2014;104(8):e25–31.
  57. Allegrante JP, Wells MT, Peterson JC. Interventions to support behavioral self-management of chronic diseases. Annu Rev Public Health. 2019;40:127–46.
  58. Newman S, Steed L, Mulligan K. Self-management interventions for chronic illness. Lancet. 2004;364(9444):1523–37.
  59. Moreno-Castilla C, Mauricio D, Hernandez M. Role of medical nutrition therapy in the management of gestational diabetes mellitus. Curr Diab Rep. 2016;16(4):1–9.
  60. Vasile FC, Preda A, Ștefan AG, Vladu MI, Forțofoiu M-C, Clenciu D, et al. An Update of Medical Nutrition Therapy in Gestational Diabetes Mellitus. J Diabetes Res. 2021;2021.
  61. Mahajan A, Donovan LE, Vallee R, Yamamoto JM. Evidenced-based nutrition for gestational diabetes mellitus. Curr Diab Rep. 2019;19(10):1–10.
  62. Wang H-K, Cheng D-C, Yang Y-M, Wang X-H, Chen Y, Zhang L, et al. The Role of High-Content Complex Dietary Fiber in Medical Nutrition Therapy for Gestational Diabetes Mellitus. Front Pharmacol. 2021;12:1509.
  63. Tsirou E, Grammatikopoulou MG, Theodoridis X, Gkiouras K, Petalidou A, Taousani E, et al. Guidelines for medical nutrition therapy in gestational diabetes mellitus: systematic review and critical appraisal. J Acad Nutr Diet. 2019;119(8):1320–39.
  64. Hernandez TL, Anderson MA, Chartier-Logan C, Friedman JE, Barbour LA. Strategies in the nutritional management of gestational diabetes. Clin Obstet Gynecol. 2013;56(4):803.
  65. Filardi T, Panimolle F, Crescioli C, Lenzi A, Morano S. Gestational diabetes mellitus: The impact of carbohydrate quality in diet. Nutrients. 2019;11(7):1549.
  66. Moreno-Castilla C, Hernandez M, Bergua M, Alvarez MC, Arce MA, Rodriguez K, et al. Low-carbohydrate diet for the treatment of gestational diabetes mellitus: a randomized controlled trial. Diabetes Care. 2013;36(8):2233–8.
  67. Hernandez TL, Brand-Miller JC. Nutrition therapy in gestational diabetes mellitus: time to move forward. Diabetes Care. 2018;41(7):1343–5.
  68. Hernandez TL, Mande A, Barbour LA. Nutrition therapy within and beyond gestational diabetes. Diabetes Res Clin Pract. 2018;145:39–50.
  69. Ponzo V, Fedele D, Goitre I, Leone F, Lezo A, Monzeglio C, et al. Diet-gut microbiota interactions and gestational diabetes mellitus (GDM). Nutrients. 2019;11(2):330.
  70. Meloncelli N, Wilkinson SA, de Jersey S. Searching for utopia, the challenge of standardized medical nutrition therapy prescription in gestational diabetes mellitus management: a critical review. In: Seminars in reproductive medicine. Thieme Medical Publishers, Inc.; 2020. p. 389–97.
  71. Laredo-Aguilera JA, Gallardo-Bravo M, Rabanales-Sotos JA, Cobo-Cuenca AI, Carmona-Torres JM. Physical activity programs during pregnancy are effective for the control of gestational diabetes mellitus. Int J Environ Res Public Health. 2020;17(17):6151.
  72. Yin Y, Li X, Tao T, Luo B, Liao S. Physical activity during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2014;48(4):290–5.
  73. Ruchat S, Mottola MF. The important role of physical activity in the prevention and management of gestational diabetes mellitus. Diabetes Metab Res Rev. 2013;29(5):334–46.
  74. Sanabria‐Martínez G, García‐Hermoso A, Poyatos‐León R, Álvarez‐Bueno C, Sánchez‐López M, Martínez‐Vizcaíno V. Effectiveness of physical activity interventions on preventing gestational diabetes mellitus and excessive maternal weight gain: a meta‐analysis. BJOG An Int J Obstet Gynaecol. 2015;122(9):1167–74.
  75. Russo LM, Nobles C, Ertel KA, Chasan-Taber L, Whitcomb BW. Physical activity interventions in pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(3):576–82.
  76. Suhail AR D, Furuya-Kanamori L, Toft E, Musa OAH, Mohamed AM, Clark J, et al. Physical activity in pregnancy prevents gestational diabetes: A meta-analysis. 2020;
  77. Tobias DK, Zhang C, Van Dam RM, Bowers K, Hu FB. Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care. 2011;34(1):223–9.
  78. Padayachee C, Coombes JS. Exercise guidelines for gestational diabetes mellitus. World J Diabetes. 2015;6(8):1033.
  79. Wang C, Guelfi KJ, Yang H-X. Exercise and its role in gestational diabetes mellitus. Chronic Dis Transl Med [Internet]. 2016;208–14. Available from: http://dx.doi.org/10.1016/j.cdtm.2016.11.006
  80. Bain E, Crane M, Tieu J, Han S, Crowther CA, Middleton P. Diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane database Syst Rev. 2015;(4).
  81. Dolatkhah N, Hajifaraji M, Shakouri SK. Nutrition therapy in managing pregnant women with gestational diabetes mellitus: a literature review. J Fam Reprod Heal. 2018;12(2):57.
  82. Carreiro MP, Nogueira AI, Ribeiro-Oliveira A. Controversies and advances in gestational diabetes—an update in the era of continuous glucose monitoring. J Clin Med. 2018;7(2):11.
  83. García‐Moreno RM, Benítez‐Valderrama P, Barquiel B, González Pérez‐de‐Villar N, Hillman N, Lora Pablos D, et al. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta‐analysis of randomized clinical trials. Diabet Med. 2022;39(1):e14703.
  84. Egan AM, Bogdanet D, Griffin TP, Kgosidialwa O, Cervar-Zivkovic M, Dempsey E, et al. A core outcome set for studies of gestational diabetes mellitus prevention and treatment. Diabetologia. 2020;63(6):1120–7.